MBX Biosciences, Inc.

MBXReported to SECin USCIK 0001776111Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at MBX Biosciences, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Azoulay SalomonChief Medical OfficerOpen-market sell$24,335370 sharesAug 5, 2026Azoulay SalomonChief Medical Officer$24,335Sell · Aug 5Open-market sell370Aug 5, 2026
Smither John WChief Financial OfficerAwardnothing paid130,000 sharesAug 4, 2026Smither John WChief Financial Officernothing paidAward · Aug 4Award130,000Aug 4, 2026
Smither John WChief Financial OfficerAwardnothing paid28,000 sharesAug 4, 2026Smither John WChief Financial Officernothing paidAward · Aug 4Award28,000Aug 4, 2026
Hoerter Steven L.President and CEOAwardnothing paid331,000 sharesAug 4, 2026Hoerter Steven L.President and CEOnothing paidAward · Aug 4Award331,000Aug 4, 2026
Hoerter Steven L.President and CEOAwardnothing paid71,000 sharesAug 4, 2026Hoerter Steven L.President and CEOnothing paidAward · Aug 4Award71,000Aug 4, 2026